Teenage social patterns make boosters a ‘good idea’, expert says GPs are soon expected to start administering booster doses to those aged 16–17 following the TGA’s provisional approval of Pfizer.
Very few adverse reports for children’s vaccination Early data suggests COVID-19 vaccination is ‘well tolerated’ in children aged 5–11 with fewer adverse reactions reported.
COVID-19 chart updated with Omicron risk of death, benefits of boosters GPs can now access up-to-date data on the benefits of booster doses for patients who have received AstraZeneca as their primary course based on risks of Omicron transmission.
How long should children wait to be vaccinated after COVID infection? COVID-19 vaccination for young children began at the same time as a spike in infections. Here is the most recent guidance available for GPs.
How long should patients wait for a booster after COVID infection? The question is likely to be asked more frequently as infections spread and millions more become eligible for booster vaccinations.
COVID risk calculator updated to include Pfizer vaccine, myocarditis probability New data has been added to the online tool, which is designed to help GPs and their patients assess the risks and benefits of vaccination.
TGA releases updated COVID booster safety data Swollen lymph nodes have been the most commonly reported adverse effect to emerge from Australia’s booster program.
Top stories of 2021: Part four A combination of freedoms, lockdowns, surging cases, mask rules, a complicated vaccine rollout, and more has made it an eventful year for GPs.
COVID-19 Vaccine Claims Scheme now open GPs will play a leading role by providing a medical report for potential claimants under the scheme.
Omicron concerns see COVID booster interval reduced The decision to reduce the interval to five months will mean improved protection against the latest variant of concern, ATAGI says.